Tag Archives: COVID-19 vaccine

SGS adds 550m2 and 16 BSL-2 laboratories to its Glasgow biosafety testing facility

(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion of its Glasgow biosafety testing facility thus helping to accelerate quality testing and reduce turnaround time for its clients. The … Read the full press release

AstraZeneca, EU agree to end legal proceedings over the delivery of the COVID-19 vaccine Vaxzevria

(PRESS RELEASE) CAMBRIDGE, 3-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced an agreement between the Company and the European Commission has been reached that puts an end of the legal proceedings over … Read the full press release

COVID-19 Vaccine AstraZeneca confirmed safe and effective at preventing COVID-19

Increased efficacy with longer inter-dose interval Protection of over 70% starting after a first dose First indication of reduction in disease transmission of up to 67% (PRESS RELEASE) CAMBRIDGE, 3-Feb-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical … Read the full press release

Saxo Bank releases its 10 Outrageous Predictions for 2021

(PRESS RELEASE) HELLERUP, Denmark, 8-Dec-2020 — /EuropaWire/ — Danish investment bank Saxo Bank announces the release of its 10 Outrageous Predictions for 2021. The predictions focus on a series of unlikely but underappreciated events which, if they were to occur, … Read the full press release

The COVID-19 vaccine based on Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant system secures 300 million doses order from the European Commission (EC)

Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system (PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused … Read the full press release

New EU / AstraZeneca deal to help EU member states access the AZD1222 COVID-19 vaccine at no profit during the pandemic

(PRESS RELEASE) CAMBRIDGE, 14-Aug-2020 — /EuropaWire/ — Global science-led biopharmaceutical company AstraZeneca (LSE/STO/NYSE: AZN) has announced it signed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the AZD1222 COVID-19 vaccine. Building … Read the full press release